Madrigal Pharmaceuticals, Inc. Stock Börse Stuttgart
Stocks
YDO1
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 467.00 EUR | -4.24% |
|
+2.48% | -5.69% |
| Market Cap | 12.37B 10.82B 9.98B 9.22B 17.5B 1,180B 17.79B 119B 46.84B 581B 46.46B 45.45B 1,999B | P/E 2026 * |
-75.9x | P/E 2027 * | 54.2x |
|---|---|---|---|---|---|
| Enterprise Value | 11.84B 10.36B 9.56B 8.83B 16.75B 1,130B 17.03B 114B 44.84B 557B 44.47B 43.51B 1,913B | EV / Sales 2026 * |
7.92x | EV / Sales 2027 * | 5.11x |
| Free-Float |
94.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 week | +2.48% | ||
| Current month | -0.45% | ||
| 1 month | +14.01% | ||
| 3 months | +5.37% | ||
| 6 months | +6.43% | ||
| Current year | -5.69% |
| 1 week | 456 |  | 492 |
| 1 month | 403.7 | | 492 |
| 3 years | 113.8 | | 519.6 |
| 5 years | 48.4 | | 519.6 |
| 10 years | 5.91 | | 519.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 08/09/2023 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 11/03/2024 |
Mark Underwood
COO | Chief Operating Officer | - | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Rebecca Taub
BRD | Director/Board Member | 74 | 01/07/2016 |
Richard Levy
BRD | Director/Board Member | 68 | 11/08/2016 |
James Daly
BRD | Director/Board Member | 64 | 27/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.24% | +2.48% | +77.50% | +134.03% | 12.37B | |
| -4.14% | -8.06% | +57.35% | +117.24% | 54.63B | |
| +1.84% | -0.66% | +75.79% | +93.87% | 54.88B | |
| -2.24% | +3.59% | +19.60% | +466.72% | 25.06B | |
| -1.60% | -6.21% | -19.69% | -14.84% | 23.14B | |
| +2.43% | +1.06% | +47.70% | -0.11% | 19.88B | |
| -3.19% | 0.00% | +33.99% | -26.87% | 17.55B | |
| -6.84% | +2.18% | +195.12% | +357.18% | 16.5B | |
| -1.05% | +1.16% | +25.08% | +196.28% | 14.2B | |
| +8.74% | +3.51% | +53.81% | - | 15.36B | |
| Average | -0.67% | -0.28% | +56.63% | +147.05% | 26.8B | |
| Weighted average by Cap. | -0.91% | -1.46% | +56.14% | +137.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.5B 1.31B 1.21B 1.11B 2.11B 143B 2.15B 14.42B 5.66B 70.26B 5.61B 5.49B 242B | 2.21B 1.93B 1.78B 1.64B 3.12B 210B 3.17B 21.27B 8.35B 104B 8.28B 8.1B 356B |
| Net income | -201M -176M -162M -150M -284M -19.17B -289M -1.94B -761M -9.44B -755M -738M -32.47B | 308M 269M 248M 229M 435M 29.34B 442M 2.97B 1.16B 14.46B 1.16B 1.13B 49.7B |
| Net Debt | -529M -463M -427M -394M -748M -50.47B -761M -5.1B -2B -24.86B -1.99B -1.94B -85.48B | -1.09B -958M -883M -816M -1.55B -104B -1.57B -10.55B -4.14B -51.43B -4.11B -4.02B -177B |
| Date | Price | Change |
|---|---|---|
| 10/07/26 | €467.00 | -4.24% |
| 09/07/26 | €487.70 | -0.29% |
| 08/07/26 | €489.10 | +2.77% |
| 07/07/26 | €475.90 | +3.39% |
| 06/07/26 | €460.30 | +1.01% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
- YDO1 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
